Research ArticleClinical Investigation
Cardiac Sympathetic Activity Estimated by 123I-MIBG Myocardial Imaging in Patients with Dilated Cardiomyopathy After ß-Blocker or Angiotensin-Converting Enzyme Inhibitor Therapy
Takuji Toyama, Yasushi Aihara, Tsutomu Iwasaki, Akira Hasegawa, Tadashi Suzuki, Ryozo Nagai, Keigo Endo, Hiroshi Hoshizaki, Shigeru Oshima and Koichi Taniguchi
Journal of Nuclear Medicine February 1999, 40 (2) 217-223;
Takuji Toyama
Yasushi Aihara
Tsutomu Iwasaki
Akira Hasegawa
Tadashi Suzuki
Ryozo Nagai
Keigo Endo
Hiroshi Hoshizaki
Shigeru Oshima


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cardiac Sympathetic Activity Estimated by 123I-MIBG Myocardial Imaging in Patients with Dilated Cardiomyopathy After ß-Blocker or Angiotensin-Converting Enzyme Inhibitor Therapy
Takuji Toyama, Yasushi Aihara, Tsutomu Iwasaki, Akira Hasegawa, Tadashi Suzuki, Ryozo Nagai, Keigo Endo, Hiroshi Hoshizaki, Shigeru Oshima, Koichi Taniguchi
Journal of Nuclear Medicine Feb 1999, 40 (2) 217-223;
Cardiac Sympathetic Activity Estimated by 123I-MIBG Myocardial Imaging in Patients with Dilated Cardiomyopathy After ß-Blocker or Angiotensin-Converting Enzyme Inhibitor Therapy
Takuji Toyama, Yasushi Aihara, Tsutomu Iwasaki, Akira Hasegawa, Tadashi Suzuki, Ryozo Nagai, Keigo Endo, Hiroshi Hoshizaki, Shigeru Oshima, Koichi Taniguchi
Journal of Nuclear Medicine Feb 1999, 40 (2) 217-223;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure
- Neuronal Dysfunction and Medical Therapy in Heart Failure: Can an Imaging Biomarker Help to "Personalize" Therapy?
- Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan
- Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study
- Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal
- Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
- Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function
- Additive Effects of Spironolactone and Candesartan on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients with Congestive Heart Failure
- Long-Term Nicorandil Therapy Improves Cardiac Sympathetic Nerve Activity After Reperfusion Therapy in Patients with First Acute Myocardial Infarction
- Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction
- Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure
- Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients
- Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure
- Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer
- Cardiac 123I-MIBG Reflects Left Ventricular Functional Reserve in Patients with Nonobstructive Hypertrophic Cardiomyopathy
- Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction
- Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity in Patients with Decompensated Congestive Heart Failure
- Addition of Valsartan to an Angiotensin-Converting Enzyme Inhibitor Improves Cardiac Sympathetic Nerve Activity and Left Ventricular Function in Patients with Congestive Heart Failure
- Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy
- Spironolactone Improves Cardiac Sympathetic Nerve Activity and Symptoms in Patients with Congestive Heart Failure
- Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon?
- Recovery of the Cardiac Adrenergic Nervous System After Long-Term {beta}-Blocker Therapy in Idiopathic Dilated Cardiomyopathy: Assessment by Increase in Myocardial 123I-Metaiodobenzylguanidine Uptake